Data updated: Mar 10, 2026
RESERPINE
RESERPINE
Approved 1955-03-24
13
Indications
--
Phase 3 Trials
70
Years on Market
Details
- Status
- Discontinued
- First Approved
- 1955-03-24
- Routes
- ORAL
- Dosage Forms
- TABLET
Companies
Viatris TABLICAPS PVT FORM Teva BUNDY Novartis WATSON LABS HALSEY MARSHALL PHARMA WHITEWORTH TOWN PLSN VALEANT PHARM INTL CYCLE MK LABS Hikma BELL PHARMA IMPAX LABS SOLVAY REXALL EVERYLIFE PUREPAC PHARM ELKINS SINN PHARMAVITE IVAX SUB TEVA PHARMS
Active Ingredient: RESERPINE
Website: ↗
RESERPINE Approval History
Loading approval history...
What RESERPINE Treats
13 FDA approvalsOriginally approved for its first indication in 1955 . Covers 13 distinct patient populations.
- Other (13)
Other
(13 approvals)- • Approved indication (Mar 1955)
- • Approved indication (Dec 1971)
- • Approved indication (Jan 1972)
- • Approved indication (Mar 1972)
- • Approved indication (Apr 1972)
- • Approved indication (Jun 1972)
- • Approved indication (Oct 1972)
- • Approved indication (Dec 1972)
- • Approved indication (Apr 1973)
- • Approved indication (Jul 1973)
- • Approved indication (Aug 1973)
- • Approved indication (Mar 1977)
- • Approved indication (Mar 1985)
🔬
Pro Active Pipeline
Ongoing clinical trials by development phase
Loading...
⭐
Pro Key Completed Trials
Completed studies with published results, ranked by significance
Loading...
📊
Trial Timeline
Full development history with FDA approval milestones
Loading...
Understanding FDA Approval Types
| Count | Type | What it means |
|---|---|---|
| - | ORIG | Original approval - drug first enters market |
| - | SUPPL - Efficacy | New indication (new disease/condition approved) |
| - | SUPPL - Labeling | Label text changes (warnings, dosing updates) |
| - | SUPPL - Manufacturing | Production changes (new facility) |
| - | SUPPL - Chemistry | Formulation changes (new dosage strength) |
Green lines in the timeline show ORIG and Efficacy approvals - the clinically meaningful milestones.
RESERPINE FDA Label Details
ProWant competitive intelligence?
See who's developing similar drugs and track their progress
Data Sources
Data sourced from official FDA and NIH databases. Click links to verify on original sources.